CP Reports Store

Current Partnering is the market-leading publisher of pharmaceutical and biotechnology dealmaking intelligence reports covering licensing agreements, collaboration agreements, co-development deals, M&A transactions, strategic alliances and partnering activity across the life sciences industry.

Our reports provide detailed analysis of real-world deal structures and financial terms, including upfront payments, milestone payments, royalty rates, equity investments and option-based deal mechanisms. Drawing on thousands of disclosed agreements, the reports enable business development and licensing professionals to benchmark comparable transactions and understand how partnerships are structured across therapeutic areas, technologies and company types.

Beyond financial terms, Current Partnering tracks key contractual provisions including exclusivity arrangements, geographic and territorial rights, regional licensing structures, development and commercialization responsibilities, co-promotion rights, manufacturing rights, intellectual property provisions and rights allocation between partners. This enables users to evaluate not only deal value but also how strategic control, risk and commercial opportunity are distributed between parties.

Coverage spans a broad range of therapeutic areas and technologies, including oncology, immunology, rare diseases, cell therapy, gene therapy, antibody-drug conjugates (ADCs), RNA therapeutics, vaccines and precision medicine.

Reports are widely relied upon globally by business development, licensing, corporate strategy, competitive intelligence and executive leadership teams to identify partners, benchmark transactions and support dealmaking decisions with real-world market evidence.

Browse our deal reports by: Deal Structure | Therapy | Technology | Development Stage | Industry | Annual Subscriptions